Association of fecal calprotectin and M2 pyruvate kinase with fecal pathogenic microorganisms in gastrointestinal infection
Rawal Medical Journal · 2024 · 49 (4) · 1
DOI: 10.5455/rmj.20240812023946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rawal Medical Journal, 2024. Verfasst von Ade Dharmawan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective: To determine the association of Fecal Calprotectin (f-CP) and M2 Pyruvate Kinase (M2-PK) with intestinal pathogens by means of the gastrointestinal syndromic panel. Methodology: This retrospective analytic study was conducted in the laboratory department a private hospital in Jakarta from October 2021 to September 2022. The inclusion criteria comprised patients aged ≥18 years with gastrointestinal complaints who had undergone f-CP and M2-PK examinations and gastrointestinal syndromic testing. The exclusion criteria were incomplete data on laboratory examinations, follow-up examinations or treatment evaluations. We used the Mann-Whitney test with p
Zitieren
APA
Dharmawan, A., & Pusparini, P. (2024). Association of fecal calprotectin and M2 pyruvate kinase with fecal pathogenic microorganisms in gastrointestinal infection. Rawal Medical Journal, 49(4), 1. https://doi.org/10.5455/rmj.20240812023946
Vancouver
Dharmawan A, Pusparini P. Association of fecal calprotectin and M2 pyruvate kinase with fecal pathogenic microorganisms in gastrointestinal infection. Rawal Medical Journal. 2024;49(4):1. doi:10.5455/rmj.20240812023946
BibTeX
@article{Dharmawan2024,
author = {Dharmawan, Ade and Pusparini, Pusparini},
title = {Association of fecal calprotectin and M2 pyruvate kinase with fecal pathogenic microorganisms in gastrointestinal infection},
journal = {Rawal Medical Journal},
year = {2024},
volume = {49},
number = {4},
pages = {1},
doi = {10.5455/rmj.20240812023946}
}
EUVIMED